AstraZeneca PLC Ordinary Shares (AZN)

Capital Expenditure

-$752.85M

Quarterly · Period ending: · USD

AZN logo

AZN Capital Expenditure

Latest reported-$752.85M
AZN Quarterly CapEx (-$333.00M → -$752.85M)
High-resolution chart · PNG

AZN capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-752,850,633
-1,538,000,000
-1,053,529,051
-1,726,000,000
-1,923,000,000
-969,000,000
-955,000,000
-1,358,000,000
-668,000,000
-1,605,000,000
-946,000,000
-879,000,000
-483,000,000
-1,470,000,000
-554,000,000
-1,111,000,000
-543,000,000
-363,000,000
-718,000,000
-660,000,000
-288,000,000
-469,000,000
-548,000,000
-705,000,000
-977,000,000
-376,000,000
-385,000,000
-341,000,000
-974,000,000
-760,000,000
-409,000,000
-269,000,000
-359,000,000
-334,000,000
-551,000,000
-353,000,000
-331,000,000
-385,000,000
-641,000,000
-366,000,000
-1,001,000,000
-306,000,000
-535,000,000
-534,000,000
-644,000,000
-1,075,000,000
-469,000,000
-415,000,000
-1,140,000,000
-728,000,000
-786,000,000
-474,000,000
-384,000,000
-414,000,000
-564,000,000
-3,572,000,000
-281,000,000
-202,000,000
-378,000,000
-244,000,000
-404,000,000
-271,000,000
-273,000,000
285,000,000
-965,000,000
-1,159,000,000
-1,957,000,000
-456,000,000
-260,000,000
-284,000,000
-493,000,000
-301,000,000
-307,000,000
-2,938,000,000
-471,000,000
-453,000,000
-350,000,000
-405,000,000
-285,000,000
-350,000,000
-415,000,000
-289,000,000
-87,000,000
-274,000,000
-217,000,000
-232,000,000
-938,000,000
553,000,000
-668,000,000
-10,000,000
0
0
0
0
0
0
-350,161,091
-285,441,911
0
-362,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.